Published in Hum Psychopharmacol on July 01, 2009
Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS | NCT00737204
Ramelteon for a Nap Prior to a Night Shift | NCT00595075
Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia | NCT00507546
Improving Sleep in Nursing Homes | NCT00576927
Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia | NCT00237497
Ramelteon for Treatment of Adult Patients With ADHD-Related Insomnia | NCT00622427
Sleepiness and Brain Function: The Effect of Armodafinil in Shift Work Sleep Disorder | NCT00688142
Cognitive enhancement by drugs in health and disease. Trends Cogn Sci (2010) 1.35
Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings. Psychopharmacology (Berl) (2011) 0.96
Change in intraindividual variability over time as a key metric for defining performance-based cognitive fatigability. Brain Cogn (2014) 0.83
Pedunculopontine arousal system physiology-Effects of psychostimulant abuse. Sleep Sci (2015) 0.75
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res (1989) 57.78
A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep (1991) 44.17
The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci (2008) 29.64
An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci (2005) 9.32
Hypothalamic regulation of sleep and circadian rhythms. Nature (2005) 8.23
Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep (1992) 7.30
Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep (1986) 6.04
Activity-based sleep-wake identification: an empirical test of methodological issues. Sleep (1994) 5.78
Grouping of brain rhythms in corticothalamic systems. Neuroscience (2005) 5.21
A putative flip-flop switch for control of REM sleep. Nature (2006) 4.67
The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci (2001) 4.33
Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther (1971) 4.30
Behavioral and physiological consequences of sleep restriction. J Clin Sleep Med (2007) 4.23
Central cholinergic systems and cognition. Annu Rev Psychol (1997) 3.80
Sleep, memory, and plasticity. Annu Rev Psychol (2006) 3.70
Sleep deprivation and vigilant attention. Ann N Y Acad Sci (2008) 3.60
Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia. Am J Psychiatry (2008) 3.51
The impact of sleep deprivation on decision making: a review. J Exp Psychol Appl (2000) 3.41
New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol (2007) 3.23
The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci (2002) 3.13
Corticothalamic resonance, states of vigilance and mentation. Neuroscience (2000) 3.07
Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci (2007) 2.95
Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology (2007) 2.88
Caffeine consumption. Food Chem Toxicol (1996) 2.84
Adenosine and sleep-wake regulation. Prog Neurobiol (2004) 2.84
Sleep, circadian rhythms, and delayed phase in adolescence. Sleep Med (2007) 2.76
Dopamine and the regulation of cognition and attention. Prog Neurobiol (2002) 2.72
From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci (2005) 2.59
Cognitive effects of nicotine. Biol Psychiatry (2001) 2.41
Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci (2005) 2.34
Clinical effects of sleep fragmentation versus sleep deprivation. Sleep Med Rev (2003) 2.25
Adrenergic pharmacology and cognition: focus on the prefrontal cortex. Pharmacol Ther (2006) 2.24
Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci (1997) 2.23
Sleep-dependent memory consolidation and reconsolidation. Sleep Med (2007) 2.21
The hypothalamic integrator for circadian rhythms. Trends Neurosci (2005) 1.99
Dreaming and the brain: toward a cognitive neuroscience of conscious states. Behav Brain Sci (2000) 1.98
Acetylcholine systems and rhythmic activities during the waking--sleep cycle. Prog Brain Res (2004) 1.95
The Pittsburgh Sleep Diary. J Sleep Res (1994) 1.94
The prefrontal cortex in sleep. Trends Cogn Sci (2002) 1.92
The St. Mary's Hospital sleep questionnaire: a study of reliability. Sleep (1981) 1.86
Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs (2004) 1.86
Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol Life Sci (2004) 1.81
Relations between performance and subjective ratings of sleepiness during a night awake. Sleep (1994) 1.79
Release of hypocretin (orexin) during waking and sleep states. J Neurosci (2002) 1.73
New treatments for cocaine dependence: a focused review. Int J Neuropsychopharmacol (2007) 1.70
Cognitive and sedative effects of benzodiazepine use. Curr Pharm Des (2002) 1.70
Chemistry of the mind: neurochemical modulation of prefrontal cortical function. J Comp Neurol (2005) 1.70
The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review. Psychopharmacology (Berl) (1980) 1.67
Sleep inertia. Sleep Med Rev (2000) 1.66
A time to think: circadian rhythms in human cognition. Cogn Neuropsychol (2007) 1.62
Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network. J Neurosci (2007) 1.61
Sleep homeostasis: a role for adenosine in humans? Biochem Pharmacol (2008) 1.59
The involvement of dopamine in the modulation of sleep and waking. Sleep Med Rev (2007) 1.55
Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state. Behav Brain Res (2000) 1.53
Fatigue in Parkinson's disease: a review. Mov Disord (2007) 1.53
Impaired declarative memory consolidation during sleep in patients with primary insomnia: Influence of sleep architecture and nocturnal cortisol release. Biol Psychiatry (2006) 1.52
Nicotinic modulation of neuronal networks: from receptors to cognition. Psychopharmacology (Berl) (2005) 1.51
5-HT system and cognition. Neurosci Biobehav Rev (1999) 1.49
Fatigue in the executive cortical network demonstrated in narcoleptics using functional magnetic resonance imaging--a preliminary study. Sleep Med (2005) 1.49
Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. Neuropsychopharmacology (2002) 1.48
Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition. Biochem Pharmacol (2007) 1.46
The effects of total sleep deprivation on cerebral responses to cognitive performance. Neuropsychopharmacology (2001) 1.45
Sleep effects of a 24-h versus a 16-h nicotine patch: a polysomnographic study during smoking cessation. Sleep Med (2006) 1.44
Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group. Ann Neurol (1998) 1.44
Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine. Psychopharmacology (Berl) (2005) 1.44
Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs (2004) 1.44
Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents. Neuroscience (2000) 1.43
The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability. Br J Clin Pharmacol (1980) 1.42
Topographical sleep EEG response to arecoline. Psychiatry Res (1990) 1.40
Power density in theta/alpha frequencies of the waking EEG progressively increases during sustained wakefulness. Sleep (1995) 1.40
Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol Psychiatry (2004) 1.38
An endogenous circadian rhythm in sleep inertia results in greatest cognitive impairment upon awakening during the biological night. J Biol Rhythms (2008) 1.36
The process of awakening: a PET study of regional brain activity patterns mediating the re-establishment of alertness and consciousness. Brain (2002) 1.34
Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther (1985) 1.32
Paradoxical (REM) sleep genesis: the switch from an aminergic-cholinergic to a GABAergic-glutamatergic hypothesis. J Physiol Paris (2007) 1.32
Evidence that wakefulness and REM sleep are controlled by a GABAergic pontine mechanism. J Neurophysiol (1999) 1.31
Caffeine attenuates waking and sleep electroencephalographic markers of sleep homeostasis in humans. Neuropsychopharmacology (2004) 1.31
Prominent burst firing of dopaminergic neurons in the ventral tegmental area during paradoxical sleep. Neuropsychopharmacology (2006) 1.30
Functional neuroimaging insights into how sleep and sleep deprivation affect memory and cognition. Curr Opin Neurol (2008) 1.29
The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Curr Med Res Opin (2006) 1.28
Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep--wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats. J Neurosci Res (2005) 1.28
The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci (2004) 1.27
Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Hum Psychopharmacol (2004) 1.26
A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. Psychopharmacology (Berl) (2000) 1.25
Prostaglandins and adenosine in the regulation of sleep and wakefulness. Curr Opin Pharmacol (2006) 1.25
A normative study of the maintenance of wakefulness test (MWT). Electroencephalogr Clin Neurophysiol (1997) 1.25
Subjective, behavioral, and physiological effects of acute caffeine in light, nondependent caffeine users. Psychopharmacology (Berl) (2006) 1.24
Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation. J Sleep Res (2005) 1.23
Adenosinergic mechanisms contribute to individual differences in sleep deprivation-induced changes in neurobehavioral function and brain rhythmic activity. J Neurosci (2006) 1.23
Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology (2004) 1.23
Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study. Prev Med (2006) 1.22
Excessive daytime sleepiness: a challenge for the practising neurologist. Brain (2001) 1.21
Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur J Pharmacol (1990) 1.20
The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. Prog Brain Res (2008) 1.20
Neurological aspects of areca and betel chewing. Addict Biol (2002) 1.19
The use of evoked potentials in sleep research. Sleep Med Rev (2007) 1.16
Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB. Neuropsychopharmacology (2006) 1.16
Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors. Neuropharmacology (1994) 1.14
Evidence from the waking electroencephalogram that short sleepers live under higher homeostatic sleep pressure than long sleepers. Neuroscience (2001) 1.14
The cognitive neuroscience of sleep: neuronal systems, consciousness and learning. Nat Rev Neurosci (2002) 2.69
Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial. JAMA (2004) 2.36
Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology (2002) 2.26
Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med (2004) 2.16
Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. Neuropsychopharmacology (2002) 1.48
Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine. Psychopharmacology (Berl) (2005) 1.44
Sleep, sleep-dependent procedural learning and vigilance in chronic cocaine users: Evidence for occult insomnia. Drug Alcohol Depend (2005) 1.44
Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study. Mayo Clin Proc (2009) 1.38
Orthostatic hypotension in Parkinson's disease: association with cognitive decline? Int J Geriatr Psychiatry (2006) 1.29
The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Curr Med Res Opin (2006) 1.28
Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients. Int Clin Psychopharmacol (2003) 1.14
A low glycaemic index breakfast cereal preferentially prevents children's cognitive performance from declining throughout the morning. Appetite (2007) 1.14
Sleep modulates word-pair learning but not motor sequence learning in healthy older adults. Neurobiol Aging (2012) 1.13
Processing of emotional reactivity and emotional memory over sleep. J Neurosci (2012) 1.13
The effects of L-theanine, caffeine and their combination on cognition and mood. Biol Psychol (2007) 1.08
Sleep architecture, cocaine and visual learning. Addiction (2008) 1.03
The effect of modafinil on cognitive function in breast cancer survivors. Cancer (2009) 1.00
Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. Int J Neuropsychopharmacol (2005) 0.98
Healthy middle-aged individuals are vulnerable to cognitive deficits as a result of increased arterial stiffness. J Hypertens (2010) 0.98
Selective effects of upper respiratory tract infection on cognition, mood and emotion processing: a prospective study. Brain Behav Immun (2007) 0.97
Selective effects of acute serotonin and catecholamine depletion on memory in healthy women. J Psychopharmacol (2004) 0.93
Cortical GABA levels in primary insomnia. Sleep (2012) 0.92
Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study. Psychoneuroendocrinology (2004) 0.92
Pharmacodynamic effects of darifenacin, a muscarinic M selective receptor antagonist for the treatment of overactive bladder, in healthy volunteers. BJU Int (2005) 0.91
Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies. Dement Geriatr Cogn Disord (2004) 0.87
Lucid dreaming and ventromedial versus dorsolateral prefrontal task performance. Conscious Cogn (2010) 0.84
Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers. Clin Ther (2006) 0.84
An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Psychopharmacology (Berl) (2008) 0.84
Sleep architecture and sleep-related mentation in securely and insecurely attached people. Attach Hum Dev (2011) 0.82
The effect of high lactose-isomaltulose on cognitive performance of young children. A double blind cross-over design study. Appetite (2011) 0.82
Differential effects of the aromas of Salvia species on memory and mood. Hum Psychopharmacol (2010) 0.81
Interaction of sleep and emotional content on the production of false memories. PLoS One (2012) 0.81
Estradiol treatment and its interaction with the cholinergic system: effects on cognitive function in healthy young women. Horm Behav (2008) 0.81
Evaluation of dementia rating scales in Parkinson's disease dementia. Am J Alzheimers Dis Other Demen (2009) 0.80
Is there an association between metabolic syndrome and cognitive function in very old adults? The Newcastle 85+ Study. J Am Geriatr Soc (2015) 0.80
Simultaneous depletion of serotonin and catecholamines impairs sustained attention in healthy female subjects without affecting learning and memory. J Psychopharmacol (2004) 0.79
Acute ingestion of different macronutrients differentially enhances aspects of memory and attention in healthy young adults. Biol Psychol (2012) 0.78
Combined D1/D2 receptor stimulation under conditions of dopamine depletion impairs spatial working memory performance in humans. Psychopharmacology (Berl) (2005) 0.78
Basal activity of the HPA axis and cognitive function in anorexia nervosa. Int J Neuropsychopharmacol (2002) 0.78
Trait and neurobiological correlates of individual differences in dream recall and dream content. Int Rev Neurobiol (2010) 0.77
Assessing the dream-lag effect for REM and NREM stage 2 dreams. PLoS One (2011) 0.77
The effects of acute tryptophan depletion on neuropsychological function, mood and movement in the healthy elderly. J Psychopharmacol (2011) 0.76
Association of salivary-assessed oxytocin and cortisol levels with time of night and sleep stage. J Neural Transm (Vienna) (2012) 0.76
Drug-induced sleep: theoretical and practical considerations. Pflugers Arch (2011) 0.76
The cognitive profile of type 1 Gaucher disease patients. J Inherit Metab Dis (2012) 0.75
Genetic variation of CHRNA4 does not modulate attention in Parkinson's disease. Neurosci Lett (2010) 0.75
Positive Association Between Nightmares and Heart Rate Response to Loud Tones: Relationship to Parasympathetic Dysfunction in PTSD Nightmares. J Nerv Ment Dis (2017) 0.75
The cognitive effects of modulating the glycine site of the NMDA receptor with high-dose glycine in healthy controls. Hum Psychopharmacol (2008) 0.75
Does a neuropsychological index of hemispheric lateralization predict onset of upper respiratory tract infectious symptoms? Br J Health Psychol (2009) 0.75
Baseline plasma GABA: its relationship to the adverse effects of acute lorazepam administration on cognition in the elderly. Neurochem Res (2004) 0.75
Cognition assessment in paediatric clinical trials. Drug Discov Today (2007) 0.75